MicroRNA-31 Regulated by the Extracellular Regulated Kinase Is Involved in Vascular Smooth Muscle Cell Growth via Large Tumor Suppressor Homolog 2*

Background: The biological role of miR-31 in vascular smooth muscle cell (VSMC) growth is currently unknown. Results: rno-miR-31 up-regulated by the extracellular regulated kinase (ERK) could increase VSMC proliferation via LATS2 (large tumor suppressor homolog 2). Conclusion: ERK/miR-31/LATS2 may represent a novel signaling pathway in VSMC growth. Significance: The study may provide a new molecular mechanism in vascular disease. Aberrant growth of vascular smooth muscle cells (VSMCs) is a major cellular event in the pathogenesis of many proliferative vascular diseases. Recently, microRNA-31 (miR-31) has been found to play a critical role in cancer cell proliferation. However, the biological role of miR-31 in VSMC growth and the mechanisms involved are currently unknown. In the present study, the expression of rat mature miR-31 (rno-miR-31) was determined in cultured VSMCs and in rat carotid arteries. We identified that rno-miR-31 is an abundant miRNA in VSMCs, and its expression was significantly increased in proliferative VSMCs and in vascular walls with neointimal growth. The up-regulation of rno-miR-31 in proliferative VSMCs was inhibited by the inhibitor of mitogen-activated protein kinase/extracellular regulated kinase (MAPK/ERK). By both gain-of-function and loss-of-function approaches, we demonstrated that rno-miR-31 had a proproliferative effect on VSMCs. We further identified that LATS2 (large tumor suppressor homolog 2) is a downstream target gene product of rno-miR-31 that is involved in rno-miR-31-mediated effect on VSMC proliferation. The LATS2 as a target gene protein of rno-miR-31 is verified in vivo in balloon-injured rat carotid arteries. The results suggest that MAPK/ERK/miR-31/LATS2 may represent a novel signaling pathway in VSMC growth. miR-31 is able to enhance VSMC proliferation via its downstream target gene product, LATS2.

[1]  Chang-Qing Deng,et al.  The effects of BuYang HuanWu Decoction and its effective components on proliferation-related factors and ERK1/2 signal transduction pathway in cultured vascular smooth muscle cells. , 2011, Journal of ethnopharmacology.

[2]  P. Tsao,et al.  MicroRNA‐26a is a novel regulator of vascular smooth muscle cell function , 2011, Journal of cellular physiology.

[3]  Da-Zhi Wang,et al.  Induction of MicroRNA-1 by Myocardin in Smooth Muscle Cells Inhibits Cell Proliferation , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Mei Han,et al.  miR‐146a and Krüppel‐like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation , 2011, EMBO reports.

[5]  Chunxiang Zhang,et al.  MicroRNAs in Vascular Disease , 2011, Journal of cardiovascular pharmacology.

[6]  Ming Yi,et al.  The role of miR-31 and its target gene SATB2 in cancer-associated fibroblasts , 2010, Cell cycle.

[7]  N. Vlahov,et al.  Micro‐RNA‐31 controls hair cycle‐associated changes in gene expression programs of the skin and hair follicle , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  Lan Xu,et al.  miR-21 and miR-31 Converge on TIAM1 to Regulate Migration and Invasion of Colon Carcinoma Cells* , 2010, The Journal of Biological Chemistry.

[9]  R. Weinberg,et al.  miR-31: A crucial overseer of tumor metastasis and other emerging roles , 2010, Cell cycle.

[10]  Jay W. Shin,et al.  miR-31 Functions as a Negative Regulator of Lymphatic Vascular Lineage-Specific Differentiation In Vitro and Vascular Development In Vivo , 2010, Molecular and Cellular Biology.

[11]  E. Dmitrovsky,et al.  MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. , 2010, The Journal of clinical investigation.

[12]  P. Gunaratne,et al.  Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other cancers. , 2010, Cancer research.

[13]  S. Chiou,et al.  miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. , 2010, Cancer research.

[14]  Y. Suárez,et al.  Cutting Edge: TNF-Induced MicroRNAs Regulate TNF-Induced Expression of E-Selectin and Intercellular Adhesion Molecule-1 on Human Endothelial Cells: Feedback Control of Inflammation , 2009, Journal of Immunology.

[15]  Ciro Indolfi,et al.  The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease , 2009, Cell Death and Differentiation.

[16]  Z. Paroo,et al.  Phosphorylation of the Human MicroRNA-Generating Complex Mediates MAPK/Erk Signaling , 2009, Cell.

[17]  John McAnally,et al.  MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. , 2009, Genes & development.

[18]  M. Hsiao,et al.  MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. , 2009, Experimental cell research.

[19]  Johanna Schneider,et al.  Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. , 2009, The Journal of clinical investigation.

[20]  Chunxiang Zhang,et al.  MicroRNA-145, a Novel Smooth Muscle Cell Phenotypic Marker and Modulator, Controls Vascular Neointimal Lesion Formation , 2009, Circulation research.

[21]  Deepak Srivastava,et al.  miR-145 and miR-143 Regulate Smooth Muscle Cell Fate Decisions , 2009, Nature.

[22]  R. Weinberg,et al.  A Pleiotropically Acting Microrna, Mir-31, Inhibits Breast Cancer Metastasis Accessed Terms of Use Detailed Terms a Pleiotropically Acting Microrna, Mir-31, Inhibits Breast Cancer Metastasis , 2022 .

[23]  Zugen Chen,et al.  MicroRNA Profiling and Head and Neck Cancer , 2009, Comparative and functional genomics.

[24]  K. Kent,et al.  Characterization of primary and restenotic atherosclerotic plaque from the superficial femoral artery: Potential role of Smad3 in regulation of SMC proliferation. , 2009, Journal of vascular surgery.

[25]  K. Mimori,et al.  Over- and under-expressed microRNAs in human colorectal cancer. , 2009, International journal of oncology.

[26]  Chunxiang Zhang,et al.  A Necessary Role of miR-221 and miR-222 in Vascular Smooth Muscle Cell Proliferation and Neointimal Hyperplasia , 2009, Circulation research.

[27]  A. Hata,et al.  Induction of MicroRNA-221 by Platelet-derived Growth Factor Signaling Is Critical for Modulation of Vascular Smooth Muscle Phenotype* , 2009, Journal of Biological Chemistry.

[28]  C. Burge,et al.  Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.

[29]  P. Campochiaro,et al.  MicroRNAs regulate ocular neovascularization. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  Chunxiang Zhang,et al.  MicroRNomics: a newly emerging approach for disease biology. , 2008, Physiological genomics.

[31]  R. Vyzula,et al.  Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer , 2008, Oncology.

[32]  Chunxiang Zhang,et al.  MicroRNA Expression Signature and Antisense-Mediated Depletion Reveal an Essential Role of MicroRNA in Vascular Neointimal Lesion Formation , 2007, Circulation research.

[33]  Jing-Yuan Fang,et al.  Inhibition of the Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway Decreases DNA Methylation in Colon Cancer Cells* , 2007, Journal of Biological Chemistry.

[34]  N. Rajewsky,et al.  The evolution of gene regulation by transcription factors and microRNAs , 2007, Nature Reviews Genetics.

[35]  X. Agirre,et al.  Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues , 2006, Molecular Cancer.

[36]  Mariette Schrier,et al.  A Genetic Screen Implicates miRNA-372 and miRNA-373 As Oncogenes in Testicular Germ Cell Tumors , 2006, Cell.

[37]  Stijn van Dongen,et al.  miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..

[38]  K. Kent,et al.  PDGF-BB Regulates p27 Expression through ERK-dependent RNA Turn-over in Vascular Smooth Muscle Cells* , 2005, Journal of Biological Chemistry.

[39]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[40]  V. Ambros.  The functions of animal microRNAs , 2004, Nature.

[41]  W. Tao,et al.  Lats2, a putative tumor suppressor, inhibits G1/S transition , 2003, Oncogene.

[42]  A. Takaori-Kondo,et al.  Inhibition of Cell Growth by Conditional Expression of kpm, a Human Homologue of Drosophila warts/lats Tumor Suppressor* , 2003, The Journal of Biological Chemistry.

[43]  L. Khachigian,et al.  ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes , 2003, Journal of cellular biochemistry.

[44]  Y. Kaneda,et al.  Inhibitory Effects of Novel AP-1 Decoy Oligodeoxynucleotides on Vascular Smooth Muscle Cell Proliferation In Vitro and Neointimal Formation In Vivo , 2002, Circulation research.

[45]  A. Takaori-Kondo,et al.  Molecular cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor , 2000, Oncogene.

[46]  N. Copeland,et al.  Title Structure , Expression , and Chromosome Mapping of LATS 2 , a Mammalian Homologue of the Drosophila Tumor Suppressor Gene lats / warts , 2022 .

[47]  E. Krebs,et al.  Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. , 1999, Cellular signalling.

[48]  T. Xu,et al.  Identifying tumor suppressors in genetic mosaics: the Drosophila lats gene encodes a putative protein kinase. , 1995, Development.

[49]  P J Bryant,et al.  The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. , 1995, Genes & development.